Workflow
Back To Basics: Why I Favor Amgen Over Johnson & Johnson
Seeking Alpha·2025-08-15 03:06

We have helped our members not only to beat S&P 500 but also avoid heavy drawdowns despite the extreme volatilities in BOTH the equity AND bond market. Join for a trial and see if our proven method can help you too. My last coverage on Johnson & Johnson (NYSE: JNJ ) was published on June 30 in an article entitled "Johnson & Johnson: Patience Will Be Rewarded". The article was prompted by the new developments surrounding its As you can tell, our core style is to provide actionable and unambiguous ideas from ...